Investors
Versant Ventures

Versant Ventures is a leading healthcare investment firm specializing in biotech. They invest in early-stage rounds such as Series A and Series B, managing $2.4 billion. With offices in the U.S., Canada, and Europe, their experienced team offers comprehensive support in investment, operations, and clinical areas. Since 1999, Versant Ventures has achieved over 70 successful exits through acquisitions or IPOs. Notable investments include Nouscom and Enterprise Therapeutics.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Recent Investments